Is There a Role for SV40 in Human Cancer?
- 10 September 2006
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (26) , 4356-4365
- https://doi.org/10.1200/jco.2005.03.7101
Abstract
The question of whether Simian Virus 40 (SV40) can cause human tumors has been one of the most highly controversial topics in cancer research during the last 50 years. The longstanding debate began with the discovery of SV40 as a contaminant in poliovirus vaccine stocks that were used to inoculate approximately 100 million children and adults in the United States between 1955 and 1963, and countless more throughout the world. Concerns regarding the potential health risk of SV40 exposure were reinforced by studies demonstrating SV40's potential to transform human cells and promote tumor growth in animal models. Many studies have attempted to assess the relationship between the potential exposure of humans to SV40 and cancer incidence. Reports of the detection of SV40 DNA in a variety of cancers have raised serious concerns as to whether the inadvertent inoculation with SV40 has led to the development of cancer in humans. However, inconsistent reports linking SV40 with various tumor types has led to conflicting views regarding the potential of SV40 as a human cancer virus. Several recent studies suggest that older detection methodologies were flawed, and the limitations of these methods could account for most, if not all, of the positive correlations of SV40 in human tumors to date. Although many people may have been exposed to SV40 by polio vaccination, there is inadequate evidence to support widespread SV40 infection in the population, increased tumor incidence in those individuals who received contaminated vaccine, or a direct role for SV40 in human cancer.Keywords
This publication has 109 references indexed in Scilit:
- CoMFA, HQSAR and molecular docking studies of butitaxel analogues with ?-tubulinJournal of Molecular Modeling, 2004
- Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal associationOncogene, 2004
- Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme ImmunoassaysClinical and Vaccine Immunology, 2003
- Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant RecipientsNew England Journal of Medicine, 2002
- Failure to confirm presence of SV40 sequences in human tumoursEuropean Journal Of Cancer, 1995
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Long-Term Follow-up of Persons Inadvertently Inoculated with SV40 as NeonatesNew England Journal of Medicine, 1981
- The Genome of Simian Virus 40Science, 1978
- Occurrence of simian virus 40 (SV40)‐reacting antibodies in sera of some patients with prostatic cancerJournal of Surgical Oncology, 1972
- DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCEThe Journal of Experimental Medicine, 1964